Literature DB >> 10505092

Who's afraid of replication-competent adenoviruses?

F J Fallaux, A J van der Eb, R C Hoeben.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10505092     DOI： 10.1038/sj.gt.3300902

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  5 in total

1.  Viral vectors for vascular gene therapy.

Authors:  Lukas Fischer; Meir Preis; Anat Weisz; Belly Koren; Basil S Lewis; Moshe Y Flugelman
Journal:  Exp Clin Cardiol       Date:  2002

Review 2.  Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.

Authors:  Zineb Belcaid; Martine L M Lamfers; Victor W van Beusechem; Rob C Hoeben
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

3.  A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Replicating Oncolytic Adenoviruses.

Authors:  Erik Yngve; Menghan Gao; Di Yu
Journal:  Methods Mol Biol       Date:  2022

4.  A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products.

Authors:  Menghan Gao; Erik Yngve; Di Yu; Chuan Jin
Journal:  Front Mol Biosci       Date:  2022-05-23

Review 5.  Gene therapy in The Netherlands: highlights from the Low Countries.

Authors:  Ellen A M Schenk-Braat; Leonie C M Kaptein; Marcella M Hallemeesch; Chris H Bangma; Rob C Hoeben
Journal:  J Gene Med       Date:  2007-10       Impact factor: 4.565
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.